Literature DB >> 22141284

Protective effects of quercetin against status epilepticus induced hippocampal neuronal injury in rats: involvement of X-linked inhibitor of apoptosis protein.

Kai Hu1, Shu-Yu Li, Bo Xiao, Fang-fang Bi, Xiao-Qin Lu, Xiao-Mei Wu.   

Abstract

Epilepsy is a common neurological disorder affecting people worldwide, and the recurrent spontaneous seizures are often seen post status epilepticus. Apoptosis and necrosis are two forms of neuronal death in post status epilepticus hippocampus, and the former has been widely studied and believed to be a major factor contributing to formation of abnormal excitatory circuit leading to refractory epileptic events. Thus, the need for development of new anti-epileptic agents remains urgent. Quercetin, a plant-derived bioflavonoid, is reported to have neuroprotective effects in neurological disease. We investigated protective effects of quercetin on status epilepticus induced hippocampal neuronal injuries in rats and focused on two major proteins, the X-linked inhibitor of apoptosis protein, a key member of the inhibitor of apoptosis protein family, and the caspase-3 protein, a common effector for the execution-phase of cell signaling apoptotic pathways. The number of apoptotic and surviving neurons were also counted in this study. We found expression alterations of X-linked inhibitor of apoptosis protein and caspase-3 protein in post status epilepticus hippocampus, along with an alteration in the number of apoptotic and surviving neurons. Furthermore, quercetin treatment in rats undergoing status epilepticus led to an interventional effect on expression of X-linked inhibitor of apoptosis protein and the caspase-3 protein, with a corresponding positive change on the number of hippocampal apoptotic and surviving neurons. Together, the study suggests neuroprotective effects of quercetin on hippocampal injury post status epilepticus and the effects may be associated with regulation of the X-linked inhibitor of apoptosis protein and the caspase-3 protein, which can be a decisive factor for apoptosis and survival of neurons in hippocampus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22141284

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  8 in total

1.  Ameliorating effect of quercetin on acute pentylenetetrazole induced seizures in rats.

Authors:  Fatih Sefil; Ibrahim Kahraman; Recep Dokuyucu; Hasan Gokce; Atakan Ozturk; Okan Tutuk; Mehmet Aydin; Umit Ozkan; Neslihan Pinar
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 2.  Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies.

Authors:  Chandra Prakash; Jyoti Tyagi; Shyam Sunder Rabidas; Vijay Kumar; Deepak Sharma
Journal:  Neuromolecular Med       Date:  2022-08-11       Impact factor: 4.103

3.  The Effect of Quercetin on Pro- and Anti-Inflammatory Cytokines in a Prenatally Stressed Rat Model of Febrile Seizures.

Authors:  Nombuso Valencia Pearl Mkhize; Lihle Qulu; Musa Vuyisile Mabandla
Journal:  J Exp Neurosci       Date:  2017-05-19

4.  Evaluation of the Anticonvulsant Effect of Brilliant Blue G, a Selective P2X7 Receptor Antagonist, in the iv PTZ-, Maximal Electroshock-, and 6 Hz-Induced Seizure Tests in Mice.

Authors:  Dorota Nieoczym; Katarzyna Socała; Piotr Wlaź
Journal:  Neurochem Res       Date:  2017-07-12       Impact factor: 3.996

5.  Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.

Authors:  Gabriella Lupo; Maria Teresa Cambria; Melania Olivieri; Concetta Rocco; Nunzia Caporarello; Anna Longo; Guido Zanghì; Mario Salmeri; Mario C Foti; Carmelina Daniela Anfuso
Journal:  J Cell Mol Med       Date:  2019-08-01       Impact factor: 5.310

6.  Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury.

Authors:  Paul G W Keddy; Kate Dunlop; Jordan Warford; Michel L Samson; Quinton R D Jones; H P Vasantha Rupasinghe; George S Robertson
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

7.  EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy.

Authors:  Li Feng; Yi Shu; Qian Wu; Tiantian Liu; Hongyu Long; Huan Yang; Yi Li; Bo Xiao
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

8.  Fabrication and evaluation of novel quercetin-conjugated Fe3O4-β-cyclodextrin nanoparticles for potential use in epilepsy disorder.

Authors:  Mona Hashemian; Maryam Ghasemi-Kasman; Shahram Ghasemi; Atefeh Akbari; Monire Moalem-Banhangi; Leila Zare; Seyed Raheleh Ahmadian
Journal:  Int J Nanomedicine       Date:  2019-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.